Haematologica
Journal Abbreviation: HAEMATOL-HEMATOL J
ISSN: 0390-6078
eISSN: 1592-8721
Publisher: Ferrata Storti Foundation
Publications (30)
HLA-C*04:09N is expressed at the cell surface and triggers peptide-specific T-cell activation. (2024)
Welters C, Welters ML, Stadler S, Bullinger L, Strobel J, Hackstein H, Dhamodaran A, et al.
Journal article
Somatic variant profiling in chronic phase pediatric chronic myeloid leukemia. (2024)
Behrens YL, Gaschler L, Nienhold R, Reinkens T, Schirmer E, Knöβ S, Strasser R, et al.
Journal article
Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation (2023)
Ruggeri A, De Wreede LC, Muller CR, Crivello P, Bonneville EF, Petersdorf EW, Socie G, et al.
Journal article
All-trans retinoic acid works synergistically with the γsecretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cells (2023)
Garcia-Guerrero E, Rodriguez-Lobato LG, Sierro-Martinez B, Danhof S, Bates S, Frenz S, Haertle L, et al.
Journal article
Meis1 supports leukemogenesis through stimulation of ribosomal biogenesis and Myc (2022)
Garcia-Cuellar MP, Prinz A, Slany R
Journal article
Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea (2022)
Allard P, Alhaj N, Lobitz S, Cario H, Jarisch A, Grosse R, Oevermann L, et al.
Journal article
Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative (2021)
Kayser S, Schlenk RF, Lebon D, Carre M, Goetze KS, Stoelzel F, Berceanu A, et al.
Journal article
RESULTS OF THE IELSG32 TRIAL AT A MEDIAN FOLLOW-UP OF 88 MONTHS DEMONSTRATE THAT MATRIX FOLLOWED BY AUTOLOGOUS TRANSPLANT IS ASSOCIATED WITH EXCELLENT SURVIVAL AND NEUROTOLERABILITY IN PATIENTS WITH PRIMARY CNS LYMPHOMA (2021)
Calimeri T, Cwynarski K, Pulczynski E, Fox CP, Schorb E, Steffanoni S, Foppoli M, et al.
Conference contribution
Fc-engineering significantly improves the recruitment of immune effector cells by anti-ICAM-1 antibody MSH-TP15 for myeloma therapy (2021)
Klausz K, Cieker M, Kellner C, Roesner T, Otte A, Krohn S, Lux A, et al.
Journal article
The process of somatic hypermutation increases polyreactivity for central nervous system antigens in primary central nervous system lymphoma (2021)
Montesinos-Rongen M, Terrao M, May C, Marcus K, Blümcke I, Hellmich M, Kuppers R, et al.
Journal article